ライフサイエンスコーパス: post injection

1 elayed-phase (18)F-FBB PET scans (90-110 min post-injection).

2 ainly signal in tumor (4.917 0.776%ID/g, 2 h post-injection).

3 ocytes reaching the tumour (P < 0.001, day 7 post-injection).

4 der accumulation is low until at least 5 min post injection.

5 one significantly decreased T(IBAT) up to 3h post injection.

6 vel at 10 weeks, and lasted up to six months post injection.

7 od glucose of the treated mice was monitored post injection.

8 body weight) and were sacrificed at 2 or 6 h post injection.

9 ith iohexol concentration data up to 300 min post injection.

10 the injected CO 2 remains in the subsurface post injection.

11 with (67)Cu-labeled-Pertuzumab even at day 5 post injection.

12 a time dependent manner and plateaus at 72 h post injection.

13 ed GFR and concentration data up to 1440 min post injection.

14 mice against Omicron by 40 fold at two weeks post injection.

15 ed deafness in Beethoven mice up to one year post injection.

16 es lethal with death happening within 30 min post injection.

17 ery long with still 66% remained on 12th day post injection.

18 nd ketamine restored pJAK2 levels within 2 h post injection.

19 ed prior to LPS/placebo injection, 2 and 5 h post injection.

20 ociated retinal or anterior segment toxicity post injection.

21 njection, which were partially recovered 5 h post injection.

22 1 antibody concentrations in the plasma 24 h post injection.

23 temic exposure and increased local retention post injection.

24 %) achieved adhesion release at mean 10 days post injection.

25 istal tubules) and sustained beyond 2 months post injection.

26 essitating euthanasia of all mice by 15 days post injection.

27 o induction of neuropathology out to 6 weeks post injection.

28 Two eyes were enucleated 6, 24 and 72 hours post injection.

29 Safety was assessed up to 48 h post-injection.

30 and total white blood cell count by 6 hours post-injection.

31 ells and macrophages) starting at around 24h post-injection.

32 triatum of active vector recipients 6 months post-injection.

33 ing programmed electrical stimulation 1 week post-injection.

34 n emission tomography images as late as 24 h post-injection.

35 creased shock-startle response 30 and 60 min post-injection.

36 cific imaging and renal clearance within 4 h post-injection.

37 ssion of osseous metastases out to six weeks post-injection.

38 ebellar regions of interest (ROIs) 40-60 min post-injection.

39 ls could be visualized by SPECT up to 6 days post-injection.

40 chronic-relapsing EAE followed for 120 days post-injection.

41 sion at 24 h, and an increase at 48 and 72 h post-injection.

42 g sc) failed to increase BLA CRF-BP mRNA 9 h post-injection.

43 uisition of a leverpress avoidance task 24 h post-injection.

44 g, im) evoked hypothermia that peaked 30 min post-injection.

45 ation, one at 60 min and another at 180 min, post-injection.

46 hich was rapid in onset and peaked 45-60 min post-injection.

47 LS unit activity, peaking at about 15-20 min post-injection.

48 tained HTT suppression for at least 7 months post-injection.

49 Food intake was determined at 2, 4, and 24 h post-injection.

50 spreading depression (SD) as early as 20 min post-injection.

51 aining diet showed an increase in intake 4 h post-injection.

52 Food intake was suppressed up to 4 days post-injection.

53 icle and were killed at 15-, 60- and 120-min post-injection.

54 e returned to baseline by approximately 24 h post-injection.

55 by 1 week, and persisted for up to 3 months post-injection.

56 ere taken at various times from 3 to 120 min post-injection.

57 al allodynia was observed between 3 and 12 h post-injection.

58 prived rats during the first and second hour post-injection.

59 latencies were attained between 10 and 12 h post-injection.

60 days after surgery and continued for 90 days post-injection.

61 howed significant differences up to 12 weeks post-injection.

62 e products are present for at least 18 weeks post-injection.

63 le hyperphagia occurred sometimes after 48 h post-injection.

64 ent, that recovered by approximately 5 weeks post-injection.

65 group counted spike-waves over a 4 h period post-injection.

66 levels, with peak decreases occurring 2-3 h post-injection.

67 ression bilaterally in granule cells at 24 h post-injection.

68 motor impairment which lasted for 15-30 min post-injection.

69 ing of AAVs by PET imaging for up to 18 days post-injection.

70 al murine model of ovarian cancer up to 24 h post-injection.

71 PET-CT scans at 1 h, day 1, day 3, and day 7 post-injection.

72 before DMPA injection and on Days 21 and 60 post-injection.

73 nhanced MRI was performed at four timepoints post-injection.

74 nd catalase (CAT), to scavenge ROS for >24 h post-injection.

75 luciferase imaging at 3rd week or > 30 days post-injection.

76 of [(89)Zr]Zr-DFO-SC16.56 at day 3 and day 7 post-injection.

77 protein and gene expression analysis at 5 h post-injection.

78 al cord, brainstem, and midbrain by 16 weeks post-injection.

79 cal forces and this effect lasted for 2 days post-injection.

80 highest uptake in TSHR + xenografts on Day 1 post-injection.

81 histologically based evaluation at 2 months post-injection.

82 le binding to bone and signal washout by 4 h post-injection.

83 ochemistry at pre-dose and 3, 7, and 14 days post-injection.

84 vel of exon skipping until at least 6 months post-injection.

85 MTD) of the particles was determined 10 days post-injection.

86 ivers than to healthy livers but only 30 min post-injection.

87 rly and blood sampled at baseline, 3 and 6 h post-injection.

88 ribution at various time points up to day 18 post-injection.

89 ower tumor uptake of 2.11 +/- 0.30% ID/g 4 h post-injection.

90 st enhancement ratio (CER) pre-injection and post-injection.

91 mice, and the signal remained strong 30 min post-injection.

92 pre-injection and 1.5, 3, 4.5, 6, and 7.5 h post-injection.

93 CG, 1.37 +/- 0.1), with peak uptake at 1.5 h post-injection.

94 n and trafficking in mice as early as 10 min post-injection.

95 s of pseudo- and true hypoxia up to 61 weeks post-injection.

96 athy with severe cardiac fibrosis by 7 weeks post-injection.

97 ide (LPS) and assessed for sickness behavior post-injection.

98 ed in measurable tumour volumes 1 to 3 weeks post-injection.

99 ssion data collected between 40 - 90 minutes post-injection.

100 ach conjugate per mouse) at 1, 7 and 13 days post-injection.

101 2, through endochondral ossification 6 weeks post-injection.

102 s revealed stable gene expression at 7months post-injection.

103 efficiently cleared from the host by 20 days post-injection.

104 bjective was safety and tolerability 28 days post-injection.

105 duction of drusen-like deposits by 2 months' post-injection.

106 bicin followed by LSFI at 3, 30, and 60 days post-injection.

107 SA/siRNA) compared to 4% (naked siRNA) 6days post-injection.

108 glioma brain compared to normal brain at 24h post-injection.

109 aged Ins2(Akita) mice even after 3months of post-injection.

110 per g of brain (%ID/g) within the first hour post-injection.

111 d FLLs were calculated and compared pre- and post-injection.

112 ction on the same day, between 1 and 14 days post-injection.

113 go in response to UV exposure up to 30 weeks post-injection.

114 als from Cy5.5-CTLs at tumors after 2-3 days post-injection.

115 ved wall motion relative to placebo 3 months post-injection.

116 ad accumulated in the U87MG tumor after 24 h post-injection.

117 with the greatest reduction observed at 12h post-injection.

118 RK was observed in glial cells as soon as 3h post-injection.

119 After 1-3 days post-injection (1-3 dpi) of BAG into the deep cerebellar

120 e 33 genes were influenced by r-bursicon 3 h post-injection (24 up-regulated and 9 down-regulated gen

121 )Cu]Cu-DOTA-c(RGDyK) ([(64)Cu]Cu-DR) at 72 h post-injection (6.20 +/- 1.61 %ID/g vs. 1.97 +/- 0.75 %I

122 d similar lung biodistribution at 30 minutes post-injection (79.3% +/- 4.2% vs 80.4% +/- 10.6% ID/g f

123 At 12 weeks post-injection, a separate and distinct pattern of struc

124 By 48 h post-injection, Abeta42-positive neurons were widespread

125 After approximately 30 days post-injection, aggregated A beta injection detrimentall

126 g PD-L1 expression in tumors as early as 4 h post-injection, allowing faster assessment compared to t

127 of a depot that released curcumin over 4days post-injection and decreased plasma AUC 7-fold.

128 m channel labeling began to increase at 23 h post-injection and reached maximum levels by 24 h.

129 ak responses (1.0 microgram) occurred 40 min post-injection and represented a 16-26-fold increase ove

130 y gene product expression peaked at 4 to 6 h post-injection and then declined to baseline.

131 centration of approximately 20 microM 15 min post-injection and was eliminated from plasma with a ter

132 This event began by 15 min post-injection and was maximal by 45 min.

133 ion of (89)Zr-panitumumab was measured 120 h post-injection and was reported as the injected dose per

134 y high tumor uptake (2.56 +/- 0.97%ID/g, 1 h post-injection) and rapid elimination from nontargeted o

135 in rhythmically expressed genes up to 2 days post injection, and in all expressed genes, we see a tre

136 gration was evident in some regions by 1 day post injection, and many newborn cells coexpressed the n

137 10-fold overexpression of NT3 from 1-21 days post-injection, and 1.7-fold overexpression at 40 days.

138 ine administration, however immune responses post-injection are not in the scope of this article.

139 ailability in the infarct/border zone at 24h post-injection as compared with free AZ7379.

140 s including tremors, which lasted up to 24 h post injection, at submicrogram amounts.

141 Each mouse was sacrificed at 1-h post injection, at which time brains were removed, snap

142 ining mature DGCs appear hyperactive 4 weeks post-injection based on immediate early gene expression,

143 k tissue, the HHR3 levels decline up to 21 h post-injection before rising to basal levels after 48 h.

144 Post-injection, both domain-specific mAbs abrogated long

145 21 control mice was tolerated up to 7 months post-injection but may induce impairment of motor coordi

146 e peptides bound amyloid deposits within 1 h post-injection, but the extent of the reactivity differe

147 and retinal expression was analyzed 4 weeks post-injection by qRT-PCR and histology.

148 inophil accumulation and preceded at 3 hours post-injection by significant increases in hepatic T hel

149 Up to 1-month post-injection, CDCEXO, but not the vehicle, decreased m

150 Twelve weeks post injection, cell-treated hearts showed preserved ECM

151 sufficient time for recovery (minimum of 3 h post injection), cellular activity was monitored for an

152 GdDOTA-CTB was visible for at least 1 month post-injection, clearing within 2 months.

153 th and a 27.69% increase in necrosis 20 days post-injection compared to Dox alone ISFIs.

154 old greater decrease in scar mass at 8 weeks post-injection compared to hCSCs (-29.2 +/- 2.7% vs. -8.

155 shrimp was extremely reduced at days 2 and 3 post-injection compared with uninfected shrimp but was f

156 pattern of binding proteins changed at 16 h post-injection, concurrent with enhanced estrogen recept

157 across all brain regions (SUV > 1 at 60 min post injection), consistent with the known distribution

158 eled Tregs can be detected in the liver 24 h post-injection, contrary to T cell control.

159 emonstrated that free DNR in the vitreous at post-injection day 14 was 66.52ng/mL for 95nm pore size

160 Even 68-h post-injection, decorin was found to reside within the t

161 lls arrive at the glomerular layer after day post injection (DPI) 7.

162 Spleen samples were collected at 40 days post injection (dpi), and sequenced.

163 naptic currents beginning approximately 14 d post-injection (dpi).

164 Forty-eight hours post injection, dramatic increases of TRH over control l

165 to the armamentarium of prophylaxis against post injection endophthalmitis.

166 ersal face mask use on rates and outcomes of post-injection endophthalmitis (PIE).

167 Post-injection endophthalmitis due to concurrent Morgane

168 Post-injection endophthalmitis due to Enterococcus faeca

169 Eleven post-injection endophthalmitis eyes of 10 patients (n =

170 considered when treating infections such as post-injection endophthalmitis.

171 At 4 h post-injection, enzyme activity was retained in the live

172 An analysis of post-injection fluorescence distribution, and RNA-seq fo

173 ntly suppressed intake during the first hour post-injection following administration into six hypotha

174 al showed the greatest difference at 16 days post injection for both Dox penetration and retention.

175 ivery was verified by intravenous blood draw post-injection for all participants.

176 PEG(4)-YS5 were sacrificed at 24 h and 168 h post-injection for quantitative alpha -particle digital

177 -mortem and post-mortem PET imaging at 120 h post-injection gave no indication of redistribution of t

178 such as good tumor uptake (3.69%ID/g at 2 h post-injection), high tumor contrast, and specificity we

179 analysis of the 2012 pre-injection and 2015 post-injection hydrologic tests that capitalizes on the

180 We examined whether delayed post-injection imaging of a new ultrasound contrast agen

181 ration rate (measured by NMP release in 24 h post injection in vitro or in vivo), and mechanical pres

182 onal damage in KA-treated hippocampi at 16 h post-injection in both maternal and virgin rats.

183 2 mRNA expression appeared ex novo at 0.5-h post-injection in cells closely associated with blood ve

184 S and corner turn tests at 14, 21 and 28days post-injection in each treatment group (P<0.05) as compa

185 aked ~6 h post-injection in lean mice, ~24 h post-injection in heavy mice, and ~ 48 h post-injection

186 Overall, PL liver signal peaked ~6 h post-injection in lean mice, ~24 h post-injection in hea

187 ing, and ex vivo biodistribution on Days 1-3 post-injection in male and female mice.

188 4 h post-injection in heavy mice, and ~ 48 h post-injection in obese mice.

189 Plasma NTproCNP was suppressed at 4 h post-injection in proportion to the prevailing level of

190 e brain 30 min post-injection ip. but not 2h post-injection in rats.

191 ing to predictions of how a drug will behave post-injection in vivo.

192 compared with a control VNAR-hFc at 18 hours post-injection in wt mice.

193 uptake in cardiac tissue (3.41%ID/g; 30 min post injection) in addition to favorable heart to nontar

194 thetic premotor areas were labeled by 6 days post-injection, including the rostral ventrolateral medu

195 red LPS bolus elicited an early (over 15 min post-injection) increase in brain ECF IL-1beta concentra

196 l and ratio of Ki67-positive CMs at 3 months post injection indicated engrafted CMs proliferated in t

197 ustains these improvements for over 2 months post-injection, indicating its therapeutic potential.

198 of intravitreal anti-VEGF injection against post-injection infectious endophthalmitis.

199 GRP also stimulated feeding but only after a post-injection interval of 10 h.

200 ight, and water intake were measured at 24 h post-injection intervals.

201 jection increased levels in the brain 30 min post-injection ip. but not 2h post-injection in rats.

202 ls, and (iii) significant risk reduction for post-injection leakage by geological, gravitational, and

203 By 12h post-injection, LPS-treated mice exhibited activated as

204 ed with ICG dose >=1 mg, albumin dissolvent, post-injection lung ventilation, radiologically solid no

205 logical events in GA, particularly at 7 days post-injection, making it a suitable model for preclinic

206 such as type of anesthesia, preparation, or post-injection medication, increased the risk of a compl

207 In post-injection mice, we observed a strong inverse correl

208 Strikingly, by 3 months post injection, micro-dystrophin was still expressed to

209 of about 0.0003% at the end of the 1000-year post-injection monitoring.

210 ere euthanized at 1 h, 6 h, and 1, 3, 7 days post-injection (n=4 or 5/group/time point).

211 ve targeting alone (7.7 +/- 0.1%ID/g at 16 h post-injection; n = 3).

212 gnificantly abrogated (2.3+/-0.5%ID/g at 48h post-injection; n=3) when mice were pre-injected with a

213 XPC-3 tumors (peak at 31.5+/-6.0%ID/g at 48h post-injection; n=3), which was significantly abrogated

214 , with 440 patients, revealed that at 1 year post injection, none of the three orthobiologic injectio

215 week and >10 nM in 3 of 4 patients 12 weeks post injection of 0.4 mg.

216 Subjects were imaged at 24 hr post injection of 360 MBq (9.7 mCi) of [123I]beta-CIT.

217 ich was confirmed after examination of somas post injection of a retrogradely transported antibody to

218 tal arrest with larval mortalities up to 73% post injection of dsRNA.

219 Standard imaging time is 60 minutes post injection of radiotracer.

220 upper air way infection was observed 2 days post injection of the second eye.

221 e intensities within tumors peaked at 10 min post-injection of Ac-IETD-Amluc, with 4.2-fold (apoptosi

222 ent MP2RAGE MR scans were performed pre- and post-injection of ESIONPs followed by advanced image co-

223 ission tomography (PET) images were acquired post-injection of free (18)F-FDG/(18)F-FLT or (18)F-FDG/

224 dopamine turnover were increased immediately post-injection only by combined exposures, and returned

225 From approximately day 50 post-injection onward, A beta-injected subjects demonstr

226 As early as 90min post injection, ova-micelle conjugates were associated w

227 ecular equilibrium was reached around 40 min post injection (p.i.) in most regions and subjects.

228 imetry methods for a wide range of potential post injection (p.i.) scan time points for different rad

229 177)Lu-SPECT imaging data (~24, 48, and 72 h post injection (p.i.)) available on first and second (17

230 r signal [from 2.5%ID/g to 12%ID/g at 1 hour post injection (p.i.)].

231 significantly higher than PYY3-36 up to 24 h post injection (p=0.0008 at 4 h, p=0.0028 at 24 h).

232 iata was observed to rise and peak at 30 min post-injection (p.i.) and declined with clearance half-l

233 ios (SUVR) measured at different time points post-injection (p.i.) with the cerebellar cortex as the

234 An hour post-injection (p.i.), 87% of the total radioactivity in

235 e obtained at 5 min, 0.5, 1, 2, 4, 8 and 24h post-injection (p.i.).

236 eling was found in the spinal cord at 2 days post-injection (p.i.).

237 ated gastric contractility for up to 120 min post-injection, P < 0.05.

238 Six hours post-injection participants completed a probabilistic in

239 Three to four hours post-injection, participants performed a probabilistic r

240 elf-administration under a PR schedule, long post-injection pauses occurred when calculated cocaine l

241 The increase was evident by 6 h post-injection, peaked at 24 h with a 4-fold increase, a

242 A post-injection period of 1000 years was simulated to mon

243 of BrdU labeling matched those of the 4 week post injection (pi) groups, suggesting that proliferatin

244 were killed at 12, 24, 36, 48, and 72 hours post injection (pi), the eyes were enucleated, and froze

245 nd 8 hours, and 1, 3, 7, 10, 14, and 60 days post injection (PI).

246 in an rpe65(-/-) model of LCA up to 6 months post-injection (PI), however the duration of this treatm

247 ERdj5 reduced visual function loss 10 weeks post-injection (PI).

248 Forty-eight hours post-injection, PLN-formulated ICLs accumulated in 95% o

249 als, with the CO(2)-H(2)O composition of the post-injection pore fluid acting as a primary control va

250 in vivo biodistribution of Lipo680 over 48 h post-injection providing a clear assessment of the uptak

251 s of caspase activity than controls 24 hours post injection, providing biochemical evidence that inhi

252 severe chronic hepatitis; moderate immediate post-injection reaction; and severe craniosynostosis wit

253 jection and persisting to the end of the 6 h post-injection recording period.

254 re and self-reported fatigue, and depression post injection relative to baseline and placebo.

255 -to- cerebellum ratios (4.6 at 25 and 37 min post injection, respectively) and reversible binding in

256 increase in drug retention at 5- and 8-days post-injection, respectively, compared to ISFIs without

257 lum ratios of 3.41, 3.24, and 3.00 at 85 min post-injection, respectively.

258 5), our system identified breathing rate and post-injection respiratory depression accurately when co

259 Controls and 1 year post-injection retinas were double labeled for protein k

260 Twenty-four hours post injection, saline maternal animals exhibited superi

261 DHS pups exhibited post-injection seizures, which were non-existent in sali

262 Here, we analyze recovered post-injection sidewall core cross-sections containing c

263 Furthermore, a comparison between pre- and post-injection sidewall cores along with an in-depth che

264 In all eyes there was post-injection spread of the retinal detachment within t

265 xpression involved retina beyond the initial post-injection subretinal bleb boundary.

266 DKO showed prolonged regeneration at day 14 post-injection, suggesting that lipin1 is critical for m

267 ll molecule angiogenesis inhibitor, 10 weeks post-injection suppresses choroidal neovascularization (

268 Post-injection survival was 2, 4, 8 h, 2 days, 2 weeks,

269 rast in mice kidneys and liver at 30 minutes post-injection than does a commercially used Gd(III) age

270 t organs and background, such that by 10 min post-injection the pancreas is the most prominent organ

271 equences in TA muscle genomic DNA by 4 weeks post injection, the levels of which were found to increa

272 At 3h, 5h, and 12h post-injection, the morphology of the SN was assessed us

273 were tracked by bioluminescence, and 4 weeks post-injection, the newly formed bone was evaluated by u

274 In summary, this study shows that at 1 year post injection, there was no superior orthobiologic as c

275 (10 mg/kg, s.c.), and sacrificed at various post-injection times to monitor the recovery of receptor

276 induced hypersensitivity post-resolution (5d post-injection), tissue repair processes were pronounced

277 ed hourly for 2 h and twice daily for 4 days post-injection together with postmortem examination of l

278 At 24 h post-injection, total enhanced green fluorescent protein

279 Although beta cell mass was preserved 8 days post-injection, total insulin content and insulin:chromo

280 o an injected protein or peptide during this post-injection transition period could affect the diffus

281 intense regions in the liver up to two weeks post injection using 9.4 T MRI.

282 Compared with the pre-injection, 4-week post-injection values of APTT and PT were increased by 0

283 tion of efferent nerve fibers began 3-7 days post-injection, versus 15-30 days for SGNs, and the loss

284 Fuel post-injection was conducted in some tests to investigat

285 CFA initiated TMDM (1d post-injection) was mainly linked to chemo-tacticity of

286 om early-phase (18)F-FBB PET scans (0-10 min post-injection), we extracted brain region-specific stan

287 ity changes occur in the brain by four weeks post-injection, well before alpha-syn pathology reaches

288 nistered GDNF (0.1-100 micrograms) at 7 days post injection were also examined.

289 rostructural changes in the pons at 12 weeks post-injection were found to predict survival time and p

290 Liver MRIs pre- and 24 h post-injection were performed to determine in vivo track

291 c.), and connectivity changes 15- and 30-min post-injection were studied.

292 Two blood samples, one early and one 300 min post injection, were sufficient to estimate iohexol clea

293 nstrated bone accumulation as earlier as 4 h post-injection, where the signal was found to be 3.6- an

294 ed and a 36-fold increase in CT contrast 4 h post injection, which makes it possible to acquire CT im

295 gnificantly affecting reward sensitivity 2 h post injection, which were partially recovered 5 h post

296 S stereoisomers were found in the liver 36 h post injection, while the 2R stereoisomers were more equ

297 us alpha-syn seeding and spreading over time post-injection with mpffs.

298 Reactivity was restored at 2- and 7-days post-injection with no group differences.

299 e-dye conjugate showed retention out to 24 h post-injection, with a 14-fold increase in signal over b

300 -acetate and is visualized as early as 2 min post-injection, with maximal activity achieved by 5 min.